NeuBase Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- NeuBase Therapeutics's estimated annual revenue is currently $5.6M per year.
- NeuBase Therapeutics's estimated revenue per employee is $201,000
Employee Data
- NeuBase Therapeutics has 28 Employees.
- NeuBase Therapeutics grew their employee count by -32% last year.
NeuBase Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is NeuBase Therapeutics?
NeuBase has developed a modular antisense technology platform with the capability to address any rare genetic disease caused by mutant proteins with a single, cohesive approach. NeuBase's platform improves upon gene silencing therapies by combining the advantages of synthetic approaches with the precision of antisense technologies. NeuBase plans to use its unparalleled antisense platform to address both repeat expansion disorders, with an initial focus on Huntington's Disease and Myotonic Dystrophy, and dominant genetic disorders.
keywords:N/A
N/A
Total Funding
28
Number of Employees
$5.6M
Revenue (est)
-32%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Pittsburgh
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $6.3M | 28 | -12% | N/A |
#2 | $15M | 28 | -20% | N/A |
#3 | $2.8M | 28 | -3% | N/A |
#4 | $4.8M | 28 | 17% | N/A |
#5 | $3.2M | 28 | -3% | N/A |